IBRX Stock: Price, Analysis & Forecast 2026
Explore IBRX stock price, technical analysis, earnings, analyst targets, and buy/hold outlook for ImmunityBio. Is IBRX stock a buy? Get balanced insights now. Introduction ImmunityBio, Inc. (IBRX stock) develops cancer immunotherapies and vaccines. It focuses on treatments like Anktiva for bladder cancer. Investors watch IBRX stock now due to rising biotech demand amid FDA approvals. … Read more